• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX, S.A. VIDAS® PROLACTIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX, S.A. VIDAS® PROLACTIN Back to Search Results
Catalog Number 30410
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 02/08/2017
Event Type  malfunction  
Event Description
A customer from (b)(6) reported a discrepancy when correlating results between the vidas® prolactin test kit ((b)(4)) and chemiluminescence methods.A patient serum sample was tested (b)(6) 2016 with vidas® and produced a result of 85.53 ng/ml.Due to this result the patient started treatment with cabergoline (0.5 mg) in (b)(6) 2016.On (b)(6) 2016 a prolactin control was performed and the result was 35.13 ng/ml.The customer reported the next control test was (b)(6) 2017 and the result was 75.18 ng/ml with vidas®.This same sample was then processed by chemiluminescence and the result was 0.7 ng /ml (rv: 4.79-23.3).A new serum sample was tested (b)(6) 2017 with vidas® and the result was 74.03 ng/ml.This sample was processed in two laboratories by chemiluminescence and the results were <2 ng/ml (rv: 4.79-23.3); and 0.5 ng/ml (rv:1.9-25).Another sample tested (b)(6) 2017 gave a 70.22 ng/ml result.Patient serum samples were then tested with mini vidas® and the results of the samples were 31.40 and 31.86 ng/ml, respectively.The customer's monthly qcv and prolactin external quality control results were as expected.The customer stated the vidas® results do not correlate with the clinical history of the patient.There is no indication or report from the hospital or treating physician to biomérieux that the discrepant result led to any adverse event related to the patient's state of health.A biomérieux internal investigation will be initiated.
 
Manufacturer Narrative
A customer from colombia reported discrepant values for the vidas® prolactin test kit when compared to the chemiluminescence method, for prolactin control samples from a patient that were tested on (b)(6) 2017.The customer did not provide a sample or test report for evaluation.An investigation was performed.A review of quality records confirmed the vidas® prolactin test kit (lot 1005172980) met specifications.The quality product laboratory has tested a calibration sample and six internal samples on a retained vidas® prolactin test kit (lot 1005172980).The results were: (b)(6).The results obtained for the calibration sample and six internal samples were within the specifications.The analysis of the control charts plus one additional sample of high concentration ([123.5-199.54] ng/ml 3is) showed that vidas® prolactin test kit (lot 1005172980) was within the trend of the other batches.The vidas® prolactin test kit (lot 1005172980) performed as intended.The customer did not provide a sample or information related to the other method used, thus further investigation is not possible.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIDAS® PROLACTIN
Type of Device
VIDAS® PROLACTIN
Manufacturer (Section D)
BIOMERIEUX, S.A.
chemin de l orme
marcy l etoile, rhone 69280
FR  69280
Manufacturer (Section G)
BIOMERIEUX, S.A.
chemin de l orme
marcy l etoile, rhone 69280
FR   69280
Manufacturer Contact
ellen weltmer
595 anglum road
st. louis, MO 63042
3147317301
MDR Report Key6587662
MDR Text Key75858362
Report Number3002769706-2017-00126
Device Sequence Number1
Product Code JJY
Combination Product (y/n)N
Reporter Country CodeCO
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 05/25/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/24/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/14/2017
Device Catalogue Number30410
Device Lot Number1005172980
Other Device ID Number03573026064969
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/11/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/23/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-